Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA. Al-Hendy A, et al. N Engl J Med. 2021 Feb 18;384(7):630-642. doi: 10.1056/NEJMoa2008283. N Engl J Med. 2021. PMID: 33596357 Free PMC article. Clinical Trial.
Uterine Fibroids: Burden and Unmet Medical Need.
Al-Hendy A, Myers ER, Stewart E. Al-Hendy A, et al. Semin Reprod Med. 2017 Nov;35(6):473-480. doi: 10.1055/s-0037-1607264. Epub 2017 Nov 3. Semin Reprod Med. 2017. PMID: 29100234 Free PMC article. Review.
Uterine fibroid therapy: the pharmacokinetic considerations.
Ali M, Al-Hendy A. Ali M, et al. Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):887-889. doi: 10.1080/17425255.2018.1506766. Epub 2018 Aug 2. Expert Opin Drug Metab Toxicol. 2018. PMID: 30058386 No abstract available.
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
Schlaff WD, Ackerman RT, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR, Feinberg EC, Hurtado SM, Kim J, Liu R, Mabey RG Jr, Owens CD, Poindexter A, Puscheck EE, Rodriguez-Ginorio H, Simon JA, Soliman AM, Stewart EA, Watts NB, Muneyyirci-Delale O. Schlaff WD, et al. N Engl J Med. 2020 Jan 23;382(4):328-340. doi: 10.1056/NEJMoa1904351. N Engl J Med. 2020. PMID: 31971678 Clinical Trial.
Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Al-Hendy A, Bradley L, Owens CD, Wang H, Barnhart KT, Feinberg E, Schlaff WD, Puscheck EE, Wang A, Gillispie V, Hurtado S, Muneyyirci-Delale O, Archer DF, Carr BR, Simon JA, Stewart EA. Al-Hendy A, et al. Am J Obstet Gynecol. 2021 Jan;224(1):72.e1-72.e50. doi: 10.1016/j.ajog.2020.07.032. Epub 2020 Jul 20. Am J Obstet Gynecol. 2021. PMID: 32702363 Free PMC article.
Non-hormonal mediators of uterine fibroid growth.
Cetin E, Al-Hendy A, Ciebiera M. Cetin E, et al. Curr Opin Obstet Gynecol. 2020 Oct;32(5):361-370. doi: 10.1097/GCO.0000000000000650. Curr Opin Obstet Gynecol. 2020. PMID: 32739973 Free PMC article. Review.
Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020.
Leppert PC, Al-Hendy A, Baird DD, Bulun S, Catherino W, Dixon D, Ducharme M, Harmon QE, Jayes FL, Paul E, Perucho AM, Segars J, Simón C, Stewart EA, Teixeira J, Tinelli A, Tschumperlin D, Zota AR. Leppert PC, et al. F S Sci. 2021 Feb;2(1):88-100. doi: 10.1016/j.xfss.2020.11.001. Epub 2020 Nov 7. F S Sci. 2021. PMID: 34124698 Free PMC article.
279 results